Page 199 - 2019_05-HaematologicaMondo-web

Mechanism of KDSR-associated thrombocytopenia
References
1. Kihara A, Igarashi Y. FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. J Biol Chem. 2004; 279(47):49243-49250.
2. Chen L, Kostadima M, Martens JH, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345(6204):1251033.
3. Battle A, Brown CD, Engelhardt BE, Montgomery SB. Genetic effects on gene expression across human tissues. Nature. 2017;550(7675):204-213.
4. Hannun YA, Luberto C, Argraves KM. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry. 2001;40(16):4893-4903.
5. Munzer P, Schmid E, Walker B, et al. Sphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formation. Am J Physiol Cell Physiol. 2014;307(10):C920-927.
6. Munzer P, Borst O, Walker B, et al. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation. Arterioscler Thromb Vasc Biol. 2014;34(1):61-71.
7. Tani M, Sano T, Ito M, Igarashi Y. Mechanisms of sphingosine and sphingo- sine 1-phosphate generation in human platelets. J Lipid Res. 2005; 46(11):2458- 2467.
8. Boyden LM, Vincent NG, Zhou J, et al. Mutations in KDSR cause recessive pro- gressive symmetric erythrokeratoderma. Am J Hum Genet. 2017;100(6):978-984.
9. Takeichi T, Torrelo A, Lee JYW, et al. Biallelic mutations in KDSR disrupt ceramide synthesis and result in a spectrum of keratinization disorders associated with
thrombocytopenia. J Invest Dermatol.
2017;137(11):2344-2353.
10. Freson K, De Vos R, Wittevrongel C, et al.
The TUBB1 Q43P functional polymor- phism reduces the risk of cardiovascular disease in men by modulating platelet func- tion and structure. Blood. 2005; 106(7):2356-2362.
11. Long T, Hicks M, Yu HC, et al. Whole- genome sequencing identifies common-to- rare variants associated with human blood metabolites. Nat Genet. 2017;49(4):568- 578.
12. Koulman A, Woffendin G, Narayana VK, Welchman H, Crone C, Volmer DA. High- resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer. Rapid Commun Mass Spectrom. 2009; 23(10):1411-1418.
13. Lu L, Koulman A, Petry CJ, et al. An unbi- ased lipidomics approach Identifies Early second trimester lipids predictive of mater- nal glycemic traits and gestational diabetes mellitus. Diabetes Care. 2016;39(12):2232- 2239.
14. Lin HF, Traver D, Zhu H, et al. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood. 2005; 106(12):3803-3810.
15. Louwette S, Labarque V, Wittevrongel C, et al. Regulator of G-protein signaling 18 con- trols megakaryopoiesis and the cilia-medi- ated vertebrate mechanosensory system. FASEB J. 2012;26(5):2125-2136.
16. Louwette S, Regal L, Wittevrongel C, et al. NPC1 defect results in abnormal platelet formation and function: studies in Niemann-Pick disease type C1 patients and zebrafish. Hum Mol Genet.2013;22(1):61- 73.
17. Moreau T, Evans AL, Vasquez L, et al.
Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun. 2016;7(11208.
18. Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic varia- tion in 60,706 humans. Nature. 2016; 536(7616):285-291.
19. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general frame- work for estimating the relative patho- genicity of human genetic variants. Nat Genet. 2014;46(3):310-315.
20. Gupta SD, Gable K, Han G, et al. Tsc10p and FVT1: topologically distinct short- chain reductases required for long-chain base synthesis in yeast and mammals. J Lipid Res. 2009;50(8):1630-1640.
21. Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008;20(6):1010-1018.
22. Italiano JE Jr, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol. 1999; 147(6):1299-1312.
23. Lentaigne C, Freson K, Laffan MA, Turro E, Ouwehand WH. Inherited platelet disor- ders: toward DNA-based diagnosis. Blood. 2016;127(23):2814-2823.
24. Bielczyk-Maczynska E, Serbanovic-Canic J, Ferreira L, et al. A loss of function screen of identified genome-wide association study Loci reveals new genes controlling hematopoiesis. PLoS Genet. 2014; 10(7):e1004450.
25. Bluteau O, Sebert M, Leblanc T, et al. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood. 2018;131(7):717-732.
haematologica | 2019; 104(5)
1045